Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Non-Pemphigoid Subepidermal Blistering Disorders

Description

The presentation focuses on non-pemphigoid subepidermal blistering disorders and highlights their varied clinical presentations and overlapping histological features. A case study on epidermolysis bullosa acquisita (EBA) outlines that it is an autoimmune disease caused by autoantibodies against collagen 7, with varied clinical manifestations resembling other blistering diseases. Diagnosis often relies on direct immunofluorescence (DIF), revealing IgG and C3 deposits along the basement membrane. Meanwhile, bullous systemic lupus also presents with similar autoantibodies and histological findings. Linear IgA bullous disease (LABD) is noted as prevalent in pediatric cases and drug-induced forms, presenting with distinct clinical patterns and histopathological features. Dermatitis herpetiformis is described as a manifestation of celiac disease, characterized by specific blistering patterns and IgA deposits in the skin. The presenter emphasizes the importance of DIF and suggests methods to increase diagnostic accuracy, such as examining hair follicles and eccrine glands for immunoreactants and considering salt split studies. A series of challenging cases illustrate the complexities in diagnosis and underscore the critical role of DIF in differentiating between similar conditions. Effective diagnostic strategies are proposed, including broad shave biopsies and targeting previously affected areas for analysis.

View more

Conclusions

  • Non-pemphigoid subepidermal blistering disorders demonstrate varied clinical presentations.
  • Histological findings alone are insufficient for definitive diagnosis due to overlapping features among conditions.
  • Direct Immunofluorescence (DIF) is essential for accurate diagnosis of epidermolysis bullosa acquisita (EBA) and related disorders.
  • EBA is characterized by autoantibodies against collagen 7 and can present in various forms that may mimic other blistering diseases.
  • The serration pattern observed in DIF can significantly enhance diagnostic accuracy, particularly in EBA.
  • For bullous systemic lupus erythematosus, serological testing is crucial as typical histological features may be absent.
  • Linear IgA Bullous Disease (LABD) can have varied presentations and be drug-induced, commonly linked to medications like vancomycin.
  • Dermatitis herpetiformis is a manifestation of celiac disease, associated with IgA deposition and requires gluten avoidance for management.
  • In diagnosing these disorders, consideration should be given to the overall clinical context and the specific immunofluorescence patterns identified.
  • Salt split studies are particularly useful to identify localized immunoreactants in certain cases, but may be less beneficial in other conditions like LABD.
  • Randie H. Kim, MD, PhD FAAD
  • Hignett E and Sami N, Ped Dermatol 2021
  • Holtsche MM, et al. Acta Derm Venereol 2021.
  • Meijer JM, et al. J Amer Acad Dermatol 2018
  • De Risi-Pugliese T, et al. Semin Arthritis Rheum. 2018
  • Sprow GS, et al. Int | Womens Dermatol 2022
  • Genovese G, et al. Orphanet J Rare Dis. 2019
  • Montagnon CM, et al. J Amer Acad Dermatol. 2021
  • Nahm WJ, et al. J Cut Pathol. 2022
  • Sally R, et al. JAAD Case Rep. 2022
  • Park JS, et al. Cureus. 2022
  • Khan S, et al. JAAD Case Reports. 2023
  • Hignet E and Sami N. Pediatr Dermatol 2021.